Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Genetic Analysis AS: Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis
Download the release

OSLO, NORWAY - June 18, 2025: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which was announced in a press release on the 05.05.2025 and approved by the Annual General Meeting on 19.05.2025 has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).

The directed issue provided the Company with approximately NOK 12.8 million by issuance of 14 890 576 new shares, before issue costs. The direct issue has now been registered with the Norwegian Register of Business Enterprises.

After this, the Company's new registered share capital is NOK 38 564 308,20 divided into 64 273 847 shares, each with a nominal value of NOK 0.60.

The Subsequent issue is still in the process of final allocation, payment and registration.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.